1. Presenter Title Presenter name

2. Living Our Mission in All We Do alleviate pain restore health extend life −written in 1960

3. Cardiac and Vascular Group $8.8B Strengthened by Our Breadth Restorative Therapies Group $6.5B Cardiac rhythm disease management Structural heart Coronary Surgical technologies Neuromodulation Spine Endovascular Diabetes Group $1.7B FY2014 Revenue by Business $17 Billion

4. Transforming to Meet Changing Needs Therapy innovationGlobalizationEconomic value Medtronic strategies Growing chronic disease Broadening stakeholders Rising cost and healthcare reform Universal healthcare needs Improved clinical outcomes Expanded access Optimized cost and efficiency Market dynamics

5. Applying Core Technologies to Advance Medical Therapy Electrical stimulation Targeted drug and biologics delivery Implantable structural devices Surgical navigation and imaging Powered and advanced energy instruments Patient and device management

6. Diabetes Neurological Spinal and orthopedic Ear, nose and throat Structural heart Urological, urogynecological and gastroenterological Endovascular Coronary Cardiac rhythm Severe spasticity Parkinson’s disease Essential tremor Dystonia* Hydrocephalus Obsessive-compulsive disorder* Brain tumors and lesions Chronic pain Subdural hematomas Cranial trauma Cervical degenerative disc disease Scoliosis Degenerative disc disease Spinal fracture Lumbar spinal stenosis Tibial fractures Orthopedic trauma Sinus diseases Thyroid conditions Otologic disorders Sleep-disordered breathing Pediatric conditions Ménière’s disease Heart valve disease Congenital heart disease Overactive bladder and urinary retention Nausea and vomiting associated with gastroparesis* Fecal incontinence Peripheral vascular disease Aortic aneurysms Coronary artery disease Atrial fibrillation Slow heart rates (bradycardia) Fast heart rates (tachycardia) Heart failure Asymptomatic heart rates Alleviating Chronic Conditions * Humanitarian device in the United States – the effectiveness for this use has not been demonstrated as of FY14. As of FY14

7. Delivering Innovative Solutions Around the World Latin AmericaMiddle East / Africa Central / Eastern Europe Greater China United States Asia Pacific Western Europe / CanadaSouth Asia international sales 46%46% countries 140 + locations 260 + strategic regions 9 Japan

8. Leading the Way lives improved 350+ clinical trials 40 + medical conditions 27,000 + patents 5,600 scientists & engineers $67M total charitable contributions 49,000 + employees $17B revenue another life is improved Every seconds 3 10M +

9. lives improved 350+ clinical trials 40 + medical conditions 23,000 + patents 5,800 scientists & engineers $64M total charitable contributions 46,000 + employees $16.6B revenue 9M + another life is improved Every seconds 3